Life Sciences
/ Biotech
The intellectual property lawyers and technical specialists of the Life Sciences/Biotech Practice Group use their legal, biotechnology and life sciences skills to evaluate current technologies and provide expert advice on intellectual property strategy and business development. They have years of experience in the pharmaceutical industry, technology transfer and licensing, life sciences patents and conducting intellectual property audits and due diligence studies. In addition to providing a full range of Life Sciences patent services, our clients look to us for licensing their technology or developing internal intellectual property policies and procedures.
The practice group includes patent attorneys and technical advisors who have years of experience and expertise in biotechnology, bioinformatics, immunology, agricultural biotechnology, gene therapy, genomics, medical devices, diagnostics, pharmaceuticals, proteomics, vaccines and drug delivery.
Many of our group members hold doctorate or advanced scientific degrees in immunology, biochemistry, botany, biotechnology and molecular biology. Many have worked as examiners at the United States Patent and Trademark Office (USPTO) or have held various positions in industry as researchers or in-house counsel.
We understand the complex USPTO procedures, as well as the scientific and business issues. This is what makes the difference for you. BSKB provides uniquely insightful technical advice and intellectual property legal counsel to a growing list of clients who enjoy the benefits of that added value.
Attorneys and Professionals
Related Articles
-
July 1, 2022
"Pharma Patents Under Fire From Federal Circuit, Petitions Say"
Bloomberg Law
BSKB's Hailey R. Bureau, Ph.D., was quoted in an article for Bloomberg Law regarding recent rulings by the US Court of Appeals for the Federal Circuit regarding strict enforcement of certain Patent Act provisions. These rulings regarding Section 112(a), a written description requirement and an enablement standard, have created a high burden for Applicants in the life science industry to overcome.
-
May 20, 2022
Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields
Chemistry Europe: European Chemical Societies Publishing
BSKB’s Hailey Bureau, Ph.D., co-authored a research article entitled “Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields”. Although prepared during her time in graduate school, the paper has now been published on May 20, 2022 in ChemPhysChem.
Related Presentations
-
May 11, 2022
Discussion of Inter Partes Review and a Patent Owner's Motion to Amend to Add Substitute Claims
-
April 27, 2022
'Code' and 'Application' Limitations Found to Connote Sufficient Structure to Avoid Means-Plus-Function Interpretation: A Discussion of Dyfan, LLC v. Target Corp.
-
April 20, 2022
Enforcing A Medical Device Patent – Definiteness And Induced Infringement
-
March 30, 2022
Recent Court Decisions
Related News
-
June 30, 2022
MaryAnne Armstrong, Ph.D. & Paul Lewis - Patent Stars for 2022
BSKB’s MaryAnne Armstrong, Ph.D. and Paul Lewis have been named Patent Stars for 2022. The annual IP Star Rankings, published by Managing IP, are awarded based on peer and client nominations. Additionally, BSKB has been named a “Recommended Firm” for Intellectual Property for 2022.
-
June 21, 2022
USPTO Update to Sequence Listing Requirements
Implementation of ST.26 for Sequence Listing requirements to become effective worldwide July 1, 2022